10.6084/m9.figshare.5128966.v1 Guess N.D. Guess N.D. Dornhorst A. Dornhorst A. Oliver N. Oliver N. Frost G.S. Frost G.S. Supplementary Material for: A Randomised Crossover Trial: The Effect of Inulin on Glucose Homeostasis in Subtypes of Prediabetes Karger Publishers 2015 Fermentable carbohydrate Prediabetes Glucagon-like peptide-1 Insulin secretion Insulin sensitivity Diabetes prevention Nutrition 2015-11-17 00:00:00 Dataset https://karger.figshare.com/articles/dataset/Supplementary_Material_for_A_Randomised_Crossover_Trial_The_Effect_of_Inulin_on_Glucose_Homeostasis_in_Subtypes_of_Prediabetes/5128966 <b><i>Background:</i></b> Fermentable carbohydrates (FCHO) have been shown to improve insulin sensitivity in normoglycaemic and insulin-resistant subjects. However, there are no data on subjects with prediabetes. We aimed to investigate the effect of the FCHO inulin, on glucose homeostasis in subjects with prediabetes. <b><i>Methods:</i></b> In a double-blind and placebo-controlled crossover study, 40 volunteers with prediabetes were randomly allocated to take 30 g/day of inulin or cellulose for 2 weeks in a crossover trial, following a 4-week dose-escalation run-in. Fasting insulin and glucose were measured for all subjects. Fifteen of the 40 subjects also underwent a meal tolerance test to assess insulin sensitivity, free fatty acids and glucagon-like peptide-1 concentrations. A subanalysis was carried out to examine any differences between the prediabetes subtypes. <b><i>Results:</i></b> Inulin was associated with a significant increase in <sub>(0-30 min)</sub>incremental AUC (iAUC) for insulin (treatment: p < 0.04) and <sub>(0-60 min)</sub>iAUC for insulin (treatment: p < 0.04) compared to control. There was a significant reduction in insulin resistance measured by the homeostatic model assessment in the isolated-impaired fasting glucose (p < 0.05) but not in the isolated-impaired glucose tolerance groups (p = 0.59). <b><i>Conclusion:</i></b> The FCHO, inulin, may have unique metabolic effects that are of particular benefit to people at risk of diabetes, which warrant further investigation.